# Medtronic Completes $650M Acquisition of SPR Therapeutics, Adding Temporary Peripheral Nerve Stimulation to Pain Portfolio

> ma · REPORTED · 2026-07-16

Medtronic completed its $650 million acquisition of SPR Therapeutics on July 16, 2026, adding SPR's FDA-cleared SPRINT Peripheral Nerve Stimulation System — a temporary, 60-day, non-opioid nerve stimulation therapy — to its neuromodulation portfolio. The deal enables Medtronic to offer earlier-stage pain intervention without the need for a permanent implant.

About Medtronic / SPR Therapeutics: SPR Therapeutics developed the SPRINT PNS System, a percutaneous peripheral nerve stimulation device providing up to 60 days of non-surgical, non-opioid pain relief for patients with chronic and acute pain conditions.

- Company: Medtronic / SPR Therapeutics
- Sector: medical devices
- Primary source: https://www.stocktitan.net/news/MDT/medtronic-completes-acquisition-of-spr-expanding-patient-access-to-bspn9uwvvr10.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.